Do you want to read an article? Please log in or register.
Interstitial lung disease in systemic lupus erythematosus: a 30-year population study
Systemic Lupus Erythematosus
Related content
Systemic Lupus Erythematosus
Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state
Rheumatology (Oxford)
Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N
doi: 10.1093/rheumatology/keaf349
Systemic Lupus ErythematosusSystemic Sclerosis
Menopausal hormone therapy and the risk of systemic lupus erythematosus and systemic sclerosis: a population-based nested case-control study
Rheumatology (Oxford)
Patasova K, Dehara M, Mantel Ä, Bixo M, Arkema E, Holmqvist M
doi: 10.1093/rheumatology/keaf004
Rheumatoid Arthritis
Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT
Arthritis Res Ther
Ramien R, Rudi T, Alten R, Krause A, Schneider M, Schaefer M, Strangfeld A, Meissner Y
doi: 10.1186/s13075-024-03449-9
Systemic Lupus Erythematosus
Enhancing systemic lupus erythematosus treatment outcomes with an early initiation of belimumab: insights from a multicenter retrospective study within the first five years
Arthritis Res Ther
Kojima K, Ichinose K, Umeda M, Shimizu T, Sato S, Suzuki T, Nakashima Y, Okada A, Horai Y, Fujikawa K, Aramaki T, Miyashita T, Furuyama M, Matsuoka N, Kawakami A
doi: 10.1186/s13075-025-03581-0
Systemic Sclerosis
Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study
Arthritis Res Ther
Hiura R, Ayano M, Uchino A, Hiura J, Ueda N, Tanaka A, Yoshizawa S, Kawano S, Sagawa F, Ota SI, Hirata A, Fujimoto S, Nishimura N, Takaki-Kuwahara A, Kimoto Y, Akashi K, Niiro H
doi: 10.1186/s13075-025-03654-0
Systemic Lupus Erythematosus
Genetic variability associates with ancestry, age at disease onset, organ involvement and disease severity in juvenile-onset systemic lupus erythematosus
Clin Immunol
Natoli V, Charras A, Hasoon MSR, Jorgensen AL, Smith EMD, Gutiérrez EC, Beresford MW, Hedrich CM, UK JSLE Cohort Study Group
doi: 10.1016/j.clim.2025.110540
Systemic Sclerosis
Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort
Rheumatology (Oxford)
Roth E, Bruni C, Petelytska L, Becker MO, Dobrota R, Jordan S, Mihai C, Muraru S, Carreira PE, De Vries-Bouwstra J, Braun-Moscovici Y, Liakouli V, Moroncini G, Bergmann C, Mouthon L, Denton CP, De Santis M, Cauli A, Adler S, Bernardino V, Truchetet ME, Vonk M, Del Galdo F, Hoffmann-Vold AM, Distler O, Elhai M, EUSTAR collaborators
doi: 10.1093/rheumatology/keaf016
COMMENTED
Systemic Lupus Erythematosus
Incidence of glaucoma in patients with systemic lupus erythematosus: a nationwide cohort study in South Korea
★ 1
Recommended and commented by
Prof. emer. Dr Josef Flammer, Faculty Member
Br J Ophthalmol
Kim JH, Kim Y, Oraha KM, Park HM, Kim YJ, Lim HW, Sung YK, Welsbie DS, Lee WJ
doi: 10.1136/bjo-2025-327897
Systemic Sclerosis
Total lung capacity is predictive of disease severity and survival in systemic sclerosis: A longitudinal analysis in 2347 patients from the French National Cohort Study
J Autoimmun
Chaigne B, Bense A, Aubourg F, Agard C, Allanore Y, Berezne A, Pugnet G, Hachulla E, Cottin V, Hot A, Dunogue B, Kanagaratnam A, Palat S, Lescoat A, Berthier S, Chatelus E, Rivière S, Launay D, Truchetet ME, Dinh-Xuan AT, Mouthon L, French Systemic Sclerosis Network
doi: 10.1016/j.jaut.2025.103391